VANCOUVER, BC / ACCESS Newswire / March 14, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce key updates to its Board of Directors ...
AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board
Dr. Dorian succeeds Peter Kendall, who previously served as Chair of the Medical Advisory Board. This leadership transition comes as AIML enters a phase of advanced clinical validation, regulatory ...
On October 10, 2024, AIML reported an impairment loss of $1,510,668, following an internal assessment of its investment in T2H. While T2H had achieved modest growth, AIML determined that the company ...
This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and digital health integration. Partnership ...
VANCOUVER, BC / ACCESS Newswire / August 21, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is issuing the following press release to clarify its disclosure ...
VANCOUVER, BC / ACCESS Newswire / March 21, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce the execution of a formal exit agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results